Updated phase I/II data for galinpepimut-S plus Keytruda in WT1-positive ovarian cancer July 1, 2021 No Comments
Dosing begins in phase Ib/II study of TTI-621 with doxorubicin in leiomyosarcoma June 30, 2021 No Comments
Elicio initiates phase I/II AMPLIFY-201 study of ELI-002 in KRAS-driven cancers June 30, 2021 No Comments
A dimeric LAIR-2 Fc fusion protein targets tumor ECM and promotes T-cell function by blocking LAIR-1 June 30, 2021 No Comments
TAT therapy with FPI-1792 plus checkpoint inhibitors eradicates colon cancer tumors in vivo June 29, 2021 No Comments
RSS